CEA Industries Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CEA Industries Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2018 | Dec 31, 2018 | $9.58M | Mar 19, 2019 |
| FY2018 | Dec 31, 2017 | $7.21M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $7.58M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $7.87M | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $1.84M | Apr 12, 2016 |
| FY2014 | Dec 31, 2013 | $50 | Apr 16, 2015 |
| FY2013 | Dec 31, 2012 | $310 | Apr 15, 2014 |
| FY2012 | Dec 31, 2011 | $335 | Apr 16, 2013 |
| FY2012 | Nov 30, 2011 | $938 | Apr 16, 2013 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.80M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $6.91M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $11.28M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $13.64M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $8.51M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $15.22M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $9.58M | Mar 24, 2020 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($219.6K) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $542.1K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $1.14M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.93M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $1.55M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.55M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.45M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $1.91M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $2.30M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $940.8K | Mar 31, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.15M) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | ($2.91M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($5.50M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($1.34M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($1.76M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($1.34M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($4.74M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($4.92M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | ($3.27M) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($5.30M) | Mar 31, 2017 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.17M) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | ($2.95M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($5.72M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($1.98M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($2.36M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($1.31M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($4.82M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($4.24M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | ($532.9K) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($3.11M) | Mar 31, 2017 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2023 | $76.5K | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $320.0K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $469.7K | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $390.2K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $521.0K | Mar 24, 2021 |
| FY2020 | Dec 31, 2018 | $32.0K | Mar 24, 2021 |
| FY2018 | Dec 31, 2017 | $319.7K | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $349.1K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $707.5K | Mar 31, 2017 |
| FY2015 | Dec 31, 2014 | $319.4K | Apr 12, 2016 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $2.94M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $3.15M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.76M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $3.66M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $3.10M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.66M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $5.97M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $5.21M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $2.20M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $3.04M | Mar 31, 2017 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($3.06M) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | ($6.13M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($3.19M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($3.21M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $818.0K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $671.8K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($2.85M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($2.27M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $103.5K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($1.69M) | Mar 31, 2017 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2023 | Dec 31, 2022 | $30.3K | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $68.7K | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $9.3K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $3.0K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $261.2K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $183.8K | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $18.2K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $62.4K | Mar 31, 2017 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $10.36M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $13.77M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $21.03M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $5.28M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $4.81M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.05M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.75M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $4.83M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $2.12M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $3.10M | Mar 31, 2017 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $1.16M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $1.51M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $6.13M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $4.89M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $6.15M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $4.40M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $2.56M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $3.42M | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $4.23M | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $5.95M | Mar 31, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $9.20M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $12.26M | Mar 27, 2025 |
| FY2024 | Dec 31, 2022 | $14.90M | Mar 27, 2025 |
| FY2023 | Dec 31, 2021 | ($3.57M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2020 | ($1.33M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2019 | ($355.6K) | Mar 29, 2022 |
| FY2020 | Dec 31, 2018 | $194.3K | Mar 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.41M | Mar 24, 2020 |
| FY2018 | Dec 31, 2016 | ($2.11M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2015 | ($2.85M) | Apr 2, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2022 | Dec 31, 2021 | $631.1K | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $631.1K | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $631.1K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $631.1K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $631.1K | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | $631.1K | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | $631.1K | Mar 31, 2017 |
| FY2014 | Dec 31, 2014 | $631.1K | Apr 16, 2015 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | ($40.34M) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | ($37.19M) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | ($34.28M) | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | ($28.78M) | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | ($27.44M) | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | ($25.68M) | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | ($24.35M) | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | ($19.25M) | Mar 19, 2019 |
| FY2017 | Dec 31, 2016 | ($14.34M) | Apr 2, 2018 |
| FY2016 | Dec 31, 2015 | ($11.06M) | Mar 31, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | $9.45M | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | $12.51M | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | $18.64M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | $2.16M | Mar 28, 2023 |
| FY2021 | Dec 31, 2020 | $2.28M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | $922.2K | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | $253.4K | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | $2.47M | Mar 19, 2019 |
| FY2018 | Dec 31, 2016 | $319.5K | Mar 19, 2019 |
| FY2017 | Dec 31, 2015 | $330.6K | Apr 2, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2014 | Dec 31, 2014 | $919.7K | Apr 16, 2015 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (4) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | (4) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | (2) | Mar 28, 2023 |
| FY2015 | Dec 31, 2015 | 0 | Apr 12, 2016 |
| FY2015 | Dec 31, 2014 | 0 | Apr 12, 2016 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | (4) | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | (4) | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 0 | Mar 29, 2024 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 793,109 | Mar 27, 2025 |
| FY2024 | Dec 31, 2023 | 673,090 | Mar 27, 2025 |
| FY2023 | Dec 31, 2022 | 7.95M | Mar 29, 2024 |
| FY2022 | Dec 31, 2021 | 1.60M | Mar 28, 2023 |
| FY2022 | Dec 30, 2021 | 240.13M | Mar 28, 2023 |
| FY2021 | Dec 29, 2021 | 240.13M | Mar 29, 2022 |
| FY2021 | Dec 31, 2020 | 1.58M | Mar 29, 2022 |
| FY2020 | Dec 31, 2019 | 228.22M | Mar 24, 2021 |
| FY2019 | Dec 31, 2018 | 224.99M | Mar 24, 2020 |
| FY2018 | Dec 31, 2017 | 206.25M | Mar 19, 2019 |